KAREN RABIN to Lymphoma
This is a "connection" page, showing publications KAREN RABIN has written about Lymphoma.
Connection Strength
0.464
-
Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study. Leukemia. 2023 05; 37(5):1138-1140.
Score: 0.464
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.